Meeting
2022 ASCO Genitourinary Cancers Symposium
The role of cytoreductive nephrectomy and systemic therapy in the management of tumor thrombus in patients with metastatic renal cell carcinoma.
Authors
Abhenil Mittal
Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada
Abhenil Mittal , Esmail Mutahar Al-Ezzi , Xuan Li , Brooke Wilson , Pavlina Spiliopoulou , Srikala S. Sridhar , Nazanin Fallah-Rad , Peter W. M. Chung , Robert James Hamilton , Aaron Richard Hansen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 345)
DOI
10.1200/JCO.2022.40.6_suppl.345
Abstract #
345
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
First Author: Romain Cohen
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of cytoreductive nephrectomy (CN) on survival in metastatic renal cell cancer (mRCC) treated with immune checkpoint inhibitors (ICI).
First Author: Stuthi Perimbeti
Poster
2021 ASCO Annual Meeting
Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).
First Author: Pooja Ghatalia
Poster
2018 Genitourinary Cancers Symposium
Improved survival rates in kidney cancer patients with brain metastases treated with modern multidisciplinary approaches.
First Author: I. Alex Bowman